BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Astex Pharma Joins The Dementia Discovery Fund As A Strategic Investor

  November 21, 2016

   · 

  3 min read
• Policy

  GlaxoSmithKline Files Regulatory Submission In U.S. For Once-Daily Closed Triple Combination Therapy FF/UMEC/VI For Patients With COPD

  November 21, 2016

   · 

  6 min read
• Pharm Country

  Daxor Corporation Announces Dividend, Patent Approval, Title Change

  November 21, 2016

   · 

  1 min read
• Reliance Precision Release: World’s First Robotic Assisted Eye Surgery

  November 21, 2016

   · 

  2 min read
• Provepharm’s Proveblue Methylene Blue Drug Substance Achieves Full Compliance With The Latest US And European Pharmacopoeial Standards

  November 21, 2016

   · 

  2 min read
• Genetown

  Spring Bank Pharmaceuticals, Inc. Announces Financing Of $15 Million

  November 21, 2016

   · 

  5 min read
• Drug Development

  Onxeo Announces 9th Positive DSMB Recommendation To Continue Livatag Relive Phase III Trial In HCC

  November 21, 2016

   · 

  4 min read
• Drug Development

  CEL-SCI Submits Response To FDA In Connection With Partial Clinical Hold On Phase III Clinical Trial

  November 21, 2016

   · 

  3 min read
• Business

  Rosetta Genomics Enters Research Collaboration Using Microrna Biomarkers To Predict Response To Leading Immuno-Oncology Drug Nivolumab In Lung Cancer Patients

  November 21, 2016

   · 

  5 min read
• BioMidwest

  New Data Presented At American Society of Nephrology Kidney Week Spotlight Baxter Internationalr’s SHARESOURCE Telehealth Platform And AMIA APD System In Supporting More Efficient Home Dialysis Care

  November 21, 2016

   · 

  5 min read